Eric Mark  Green net worth and biography

Eric Green Biography and Net Worth

Eric M. Green has served as President and Chief Executive Officer of West Pharmaceutical Services, Inc. since April 2015, and as the chair of the board since May 2022. As CEO, Eric leads over 10,000 team members focused on the mission to contain and deliver injectable therapies that improve patients’ lives.

The Company’s 2022 net sales of $2.89 billion reflect the annual production of more than 47 billion components and devices worldwide. Eric is responsible for leading West’s market-led business strategy, focused on tailoring the Company’s approach to the specific needs of Biologics, Generics, Pharmaceutical and Diagnostic customer groups.

Prior to joining West, Eric served as Executive Vice President and President for the Research Markets business unit for Sigma-Aldrich Corporation, where he gained extensive international experience, serving in a number of regional, commercial and operational leadership roles over his more than 20-year career there.

Eric earned his Master of Business Administration from the Olin Business School-Washington University in St. Louis, Mo. and bachelor’s degree in chemistry from Bethel University in St. Paul, Minn. Eric serves as a member of Bethel University’s Board of Trustees, and also as an independent director and member of the board for Ecolab.

What is Eric Mark Green's net worth?

The estimated net worth of Eric Mark Green is at least $47.66 million as of May 7th, 2024. Mr. Green owns 152,908 shares of West Pharmaceutical Services stock worth more than $47,656,836 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Green may own. Additionally, Mr. Green receives a salary of $2,900,000.00 as CEO at West Pharmaceutical Services. Learn More about Eric Mark Green's net worth.

How old is Eric Mark Green?

Mr. Green is currently 54 years old. There are 7 older executives and no younger executives at West Pharmaceutical Services. Learn More on Eric Mark Green's age.

What is Eric Mark Green's salary?

As the CEO of West Pharmaceutical Services, Inc., Mr. Green earns $2,900,000.00 per year. Learn More on Eric Mark Green's salary.

How do I contact Eric Mark Green?

The corporate mailing address for Mr. Green and other West Pharmaceutical Services executives is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. West Pharmaceutical Services can also be reached via phone at (610) 594-2900 and via email at [email protected]. Learn More on Eric Mark Green's contact information.

Has Eric Mark Green been buying or selling shares of West Pharmaceutical Services?

Eric Mark Green has not been actively trading shares of West Pharmaceutical Services over the course of the past ninety days. Most recently, Eric Mark Green sold 66,000 shares of the business's stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $366.65, for a transaction totalling $24,198,900.00. Following the completion of the sale, the chief executive officer now directly owns 152,908 shares of the company's stock, valued at $56,063,718.20. Learn More on Eric Mark Green's trading history.

Who are West Pharmaceutical Services' active insiders?

West Pharmaceutical Services' insider roster includes Silji Abraham (Insider), Bernard Birkett (SVP), Annette Favorite (VP), Eric Green (CEO), Thomas Hofmann (Director), Quintin Lai (VP), George Miller (VP), Cindy Reiss-Clark (Insider), Chad Winters (CAO), and Patrick Zenner (Director). Learn More on West Pharmaceutical Services' active insiders.

Are insiders buying or selling shares of West Pharmaceutical Services?

In the last twelve months, insiders at the medical instruments supplier sold shares 10 times. They sold a total of 145,140 shares worth more than $52,554,297.12. The most recent insider tranaction occured on October, 29th when VP Charles Witherspoon sold 703 shares worth more than $218,211.20. Insiders at West Pharmaceutical Services own 0.5% of the company. Learn More about insider trades at West Pharmaceutical Services.

Information on this page was last updated on 10/29/2024.

Eric Mark Green Insider Trading History at West Pharmaceutical Services

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/7/2024Sell66,000$366.65$24,198,900.00152,908View SEC Filing Icon  
2/27/2024Sell64,132$359.85$23,077,900.20152,908View SEC Filing Icon  
5/9/2023Sell44,000$363.10$15,976,400.00134,574View SEC Filing Icon  
3/7/2023Sell44,000$322.35$14,183,400.0085,705View SEC Filing Icon  
12/5/2022Sell44,000$238.99$10,515,560.00114,922View SEC Filing Icon  
5/21/2015Buy18,300$54.89$1,004,487.00View SEC Filing Icon  
See Full Table

Eric Mark Green Buying and Selling Activity at West Pharmaceutical Services

This chart shows Eric Mark Green's buying and selling at West Pharmaceutical Services by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

West Pharmaceutical Services Company Overview

West Pharmaceutical Services logo
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Read More

Today's Range

Now: $311.67
Low: $299.36
High: $312.57

50 Day Range

MA: $306.23
Low: $286.40
High: $344.12

2 Week Range

Now: $311.67
Low: $265.00
High: $413.70

Volume

437,683 shs

Average Volume

822,261 shs

Market Capitalization

$22.57 billion

P/E Ratio

46.24

Dividend Yield

0.28%

Beta

1